CMA Unconditionally Clears Unite Group's Acquisition of Empiric Student Property

CMA clears Unite’s takeover of Empiric: what just happened

The Competition and Markets Authority has unconditionally cleared The Unite Group’s acquisition of Empiric Student Property at Phase 1. That is a big de-risking moment. The CMA condition in the Scheme of Arrangement is now satisfied, and the deal moves to the Court stage.

For context, a Scheme of Arrangement is a court-approved process often used for UK takeovers. Shareholders already voted in favour on 6 October 2025, so the main remaining hurdles are the Court Sanction Hearing and the formal court order being filed with Companies House.

The boards of both companies say the Court Sanction Hearing is set for 26 January 2026, with an expected Effective Date of 28 January 2026. In short, we are into the endgame.

Dividend changes and the cash haircut explained

There is a tidy bit of mechanics here that matters for your payout. Empiric will not declare a fourth quarterly dividend for the year ended 31 December 2025. In return, Unite has confirmed a small reduction to the cash element of the offer.

The cash consideration per Empiric share will be reduced by 1.275 pence, from 32 pence to 30.725 pence. Why 1.275 pence? Because Empiric paid 2.775 pence in aggregate for the first three quarters, which is 1.275 pence more than the 1.5 pence threshold set in the deal terms.

Crucially, if the timetable holds and you keep your New Unite Shares after completion, you will be entitled to the Unite Final Dividend, which is expected to represent approximately two thirds of Unite’s total expected dividend for 2025. The boards’ expectation is that, on that basis, Empiric shareholders who stay invested will end up with roughly what they would have received had the acquisition not happened.

Two takeaways:

• Cash now is trimmed by 1.275 pence per share.
• Ongoing holders of New Unite Shares should recoup the value via Unite’s Final Dividend, provided the deal completes on the updated timetable.

Key numbers at a glance

Cash consideration per Empiric share	Reduced to 30.725 pence (from 32 pence)
Reduction amount	1.275 pence
Empiric permitted dividends (Q1-Q3 2025)	2.775 pence (aggregate)
Reference threshold in deal terms	1.5 pence
Court Sanction Hearing	26 January 2026
Expected Effective Date	28 January 2026
Long Stop Date	11.59 p.m. on 30 June 2026

Updated timetable: dates Empiric investors should mark

Here is the revised sequencing from the RNS. All times are London time and may change if the parties update the schedule.

• 26 January 2026: Court Sanction Hearing. All Empiric shareholders have the right to attend.
• 5.00 p.m. on 27 January 2026: Last day for dealings in Empiric shares and for registration of transfers and disablement in CREST (the UK electronic settlement system).
• 6.00 p.m. on 27 January 2026: Scheme Record Time. This fixes the register for who gets the scheme consideration.
• By 7.30 a.m. on 28 January 2026: Suspension of Empiric’s listing and trading.
• 28 January 2026: Effective Date. This is when the court order is delivered to the Registrar of Companies and the scheme takes legal effect.
• By 8.00 a.m. on 29 January 2026: New Unite Shares issued to Empiric shareholders, admitted to trading, and Empiric’s listing cancelled.
• Within 14 days after the Effective Date: Cheques dispatched and CREST accounts credited for cash consideration. Fractional entitlements to New Unite Shares will be aggregated and sold as soon as reasonably practicable after the Effective Date.

What still needs to happen before completion

Despite the CMA clearance, the acquisition is not yet done. The Court must sanction the Scheme and the court order must be filed. Those are standard steps for Part 26 schemes but they are conditions nonetheless.

The timetable can still move, and the RNS makes clear any change will be announced via a Regulatory Information Service and posted on Empiric’s website. The Long Stop Date is 30 June 2026, which is the ultimate backstop by which the Scheme must become effective unless extended with consent.

My view: positive de-risking, minor trade-off on cash

On balance, this is a clear positive. Unconditional Phase 1 clearance removes the main regulatory uncertainty and should narrow any residual deal risk discount in Empiric’s price. The pathway to completion is laid out with specific dates, which the market likes.

The 1.275 pence reduction in cash is a modest trade-off and is the mechanical consequence of Empiric not paying a fourth quarterly dividend. For shareholders who stick around for the New Unite Shares, the expectation is you are made whole via Unite’s Final Dividend. If you intended to sell out before completion, you will feel that reduction more keenly.

The remaining risks are largely procedural: the court process and the possibility of timetable slippage. The RNS explicitly ties the dividend equivalence to the deal proceeding on the updated timetable, so that is the date to watch. Otherwise, this reads like a transaction on the home straight.

What to watch next

• 26 January 2026: outcome of the Court Sanction Hearing.
• 28 January 2026: confirmation that the Scheme is effective.
• 29 January 2026: receipt of New Unite Shares and trading commencement, plus cancellation of Empiric’s listing.
• Within 14 days of the Effective Date: settlement of cash consideration and CREST credits.

Quick jargon buster

• Scheme Record Time: the cut-off time for determining which holders are entitled to the scheme consideration.
• Effective Date: the date the court order is filed and the Scheme legally completes.
• Long Stop Date: the latest date by which the deal must complete unless extended with approvals.
• CREST: the UK’s electronic settlement system for shares.

If you want the official timetable updates or scheme documents, the companies will post them on their investor pages as flagged in the RNS.